Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

An atypical case of a pulmonary mass in an immunocompromised patient.

Cardinaels N, Van Rompaey W, Bos S, Bode H, Tousseyn T, Van Bleyenbergh P.

Acta Clin Belg. 2019 Aug 17:1-5. doi: 10.1080/17843286.2019.1655232. [Epub ahead of print]

PMID:
31423951
2.

Do-not-resuscitate orders as part of advance care planning in patients with COPD.

Raskin J, Vermeersch K, Everaerts S, Van Bleyenbergh P, Janssens W.

ERJ Open Res. 2018 Feb 16;4(1). pii: 00116-2017. doi: 10.1183/23120541.00116-2017. eCollection 2018 Jan.

3.

Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis.

Van de Kerkhove C, Goeminne PC, Kicinski M, Nawrot TS, Lorent N, Van Bleyenbergh P, De Boeck K, Dupont LJ.

J Cyst Fibros. 2016 Nov;15(6):802-808. doi: 10.1016/j.jcf.2016.09.002. Epub 2016 Oct 5.

4.

First-in-man observation of Talaromyces marneffei-transmission by organ transplantation.

Hermans F, Ombelet S, Degezelle K, Testelmans D, Van Raemdonck DE, Verleden GM, Verbeken EK, Van Bleyenbergh P, Lagrou K, Vos R.

Mycoses. 2017 Mar;60(3):213-217. doi: 10.1111/myc.12574. Epub 2016 Sep 30.

PMID:
27687582
5.

Normalization of mediastinal widening after successful treatment of mediastinal tuberculosis.

Raskin J, Van Bleyenbergh P.

Acta Clin Belg. 2016 Aug;71(4):269-70. doi: 10.1080/17843286.2016.1175704. Epub 2016 May 5.

PMID:
27149681
6.

Disseminated Mycobacterium genavense infection in a patient with immunosuppressive therapy and lymphoproliferative malignancy.

Numbi N, Demeure F, Van Bleyenbergh P, De Visscher N.

Acta Clin Belg. 2014 Apr;69(2):142-5. doi: 10.1179/0001551213Z.00000000016.

PMID:
24724760
7.

Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening.

Debeuckelaere C, De Munter P, Van Bleyenbergh P, De Wever W, Van Assche G, Rutgeerts P, Vermeire S.

J Crohns Colitis. 2014 Jun;8(6):550-7. doi: 10.1016/j.crohns.2013.11.008. Epub 2013 Dec 2.

PMID:
24295645
8.

A cohort description and analysis of the effect of gabapentin on idiopathic cough.

Van de Kerkhove C, Goeminne PC, Van Bleyenbergh P, Dupont LJ.

Cough. 2012 Nov 1;8(1):9. doi: 10.1186/1745-9974-8-9.

9.

Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis.

Pauwels A, Decraene A, Blondeau K, Mertens V, Farre R, Proesmans M, Van Bleyenbergh P, Sifrim D, Dupont LJ.

Chest. 2012 Jun;141(6):1568-1574. doi: 10.1378/chest.11-1573. Epub 2011 Dec 1.

PMID:
22135379
10.

Consumption patterns and in vitro resistance of Streptococcus pneumoniae to fluoroquinolones.

Simoens S, Verhaegen J, van Bleyenbergh P, Peetermans WE, Decramer M.

Antimicrob Agents Chemother. 2011 Jun;55(6):3051-3. doi: 10.1128/AAC.00019-11. Epub 2011 Apr 4.

11.

Three colleagues with sarcoidosis?

Sibille A, Van Bleyenbergh P, Lagrou K, Verstraeten A, Wuyts W.

Eur Respir J. 2011 Apr;37(4):962-4. doi: 10.1183/09031936.00131810. No abstract available.

12.

New therapies for fungal pneumonia.

Maertens J, Meersseman W, Van Bleyenbergh P.

Curr Opin Infect Dis. 2009 Apr;22(2):183-90. doi: 10.1097/QCO.0b013e328328cfff. Review.

PMID:
19276884
13.

Primary cryptococcal cellulitis in a lung transplant recipient.

Van Grieken SA, Dupont LJ, Van Raemdonck DE, Van Bleyenbergh P, Verleden GM.

J Heart Lung Transplant. 2007 Mar;26(3):285-9.

PMID:
17346632
14.

Recurrent flu-like illness with migrating pulmonary infiltrates of unknown aetiology.

Van Bleyenbergh P, Nemery B, Nolard N, Demedts M.

Respir Med. 2001 May;95(5):348-56.

15.

A breathless accountant who blew up balloons.

Thomeer M, Van Bleyenbergh P, Nemery B, Demedts M.

Lancet. 1999 Jul 10;354(9173):124. No abstract available.

PMID:
10408489
16.

Hemolytic-uremic syndrome caused by gemcitabine.

Nackaerts K, Daenen M, Vansteenkiste J, Vandevelde A, Van Bleyenbergh P, Demedts M.

Ann Oncol. 1998 Dec;9(12):1355. Review. No abstract available.

PMID:
9932169

Supplemental Content

Loading ...
Support Center